Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, August 6, 2009

ArQule cuts losses in Q2

By Julie M. Donnelly

ArQule Inc., the Woburn-based biotechnology company focusing on cancer treatments, has cut its losses almost in half by reducing research and development costs, reducing administrative costs and recognizing revenue from research collaborations.

The company reported a loss of $8.3 million for the second quarter of 2009, down from $16 million for the corresponding period last year. The company reduced administrative costs to $3.2 million for the quarter, down from $4.2 million for the second quarter of 2008. Research and development costs were trimmed to $12.6 million for the second quarter from $15 million for the same period last year.

The company took in $6.1 million in research and development revenue in the quarter ending June 30, 2009, up from $2.6 million for the second quarter in 2008. The revenue stems mostly from collaborations with the Japanese pharmaceutical company Daiichi Sankyo covering two different drug programs.

ArQule had $117.4 million in cash, cash equivalents and marketable securities on hand on June 30, down from $141.9 million on December 31, 2008.

ArQule confirmed its previous guidance that the company has a total cash burn for 2009 of between $46 million and $49 million. The company expects its net loss to range between $44 million and $47 million.

ArQule’s (Nasdaq:ARQL) stock was trading at $5.54 in midday trading on Thursday, down from $5.73 at the previous close.

 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Women to Watch: What makes them special

By James M. Connolly Intelligence, dedicated, leader, innovative, hard-working — they’re all words associated with the 11 women recognized with the Mass High Tech Women to Watch awards this morning. But back at the office we were talking how commonly another word has to be applied to the 2010 honorees and their 60 predecessors. It’s their humility. It’s so striking. We at Mass High T...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio